Breckenridge Announces Approval of its ANDA for Cabazitaxel Intravenous Solution (generic for Jevtana Kit®)

/PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announces today that the U.S. Food and Drug Administration has granted approval of its Abbreviated New Drug...

Related Keywords

Japan ,United States ,Towa ,Yamaguchi ,India ,Berlin ,Germany ,Robert Gasparino ,Drug Administration ,Breckenridge Pharmaceutical Inc ,Business Development ,Natco Pharma ,Breckenridge Pharmaceutical ,Abbreviated New Drug Application ,Cabazitaxel Intravenous Powder ,Jevtana Kit ,Towa Pharmaceutical ,Pharma Limited ,Associate Vice President ,